72 related articles for article (PubMed ID: 30901113)
1. Evaluation of two tuberculosis PCR assays for routine use in a clinical setting of low population and low tuberculosis prevalence.
Luukinen BV; Vuento R; Hirvonen JJ
APMIS; 2019 Jun; 127(6):462-467. PubMed ID: 30901113
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a semi-automated Seegene PCR workflow with MTB, MDR, and NTM detection for rapid screening of tuberculosis in a low-prevalence setting.
Luukinen BV; Vuento R; Hirvonen JJ
APMIS; 2020 May; 128(5):406-413. PubMed ID: 32202675
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Abbott RealTime MTB and RealTime MTB INH/RIF Assays for Direct Detection of Mycobacterium tuberculosis Complex and Resistance Markers in Respiratory and Extrapulmonary Specimens.
Hofmann-Thiel S; Molodtsov N; Antonenka U; Hoffmann H
J Clin Microbiol; 2016 Dec; 54(12):3022-3027. PubMed ID: 27733630
[TBL] [Abstract][Full Text] [Related]
4. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
6. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.
Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M
Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of
Ruiz P; Causse M; Vaquero M; Gutierrez JB; Casal M
Infect Drug Resist; 2017; 10():463-467. PubMed ID: 29263682
[TBL] [Abstract][Full Text] [Related]
8. [A study of the value of three molecular diagnostic techniques in the diagnosis of tuberculosis].
Huang F; Dang L; Sun H; Yang H; Wu X
Zhonghua Jie He He Hu Xi Za Zhi; 2015 Sep; 38(9):680-5. PubMed ID: 26703773
[TBL] [Abstract][Full Text] [Related]
9. Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
Tadesse M; Aragaw D; Dimah B; Efa F; Abebe G
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S48-S49. PubMed ID: 28043605
[TBL] [Abstract][Full Text] [Related]
10. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
[TBL] [Abstract][Full Text] [Related]
11. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
[TBL] [Abstract][Full Text] [Related]
12. The Abbott RealTime MTB assay and the Cepheid GeneXpert assay show comparable performance for the detection of Mycobacterium tuberculosis in sputum specimens.
Wang SF; Ou XC; Li Q; Zheng HW; Wang YF; Zhao YL
Int J Infect Dis; 2016 Apr; 45():78-80. PubMed ID: 26948480
[TBL] [Abstract][Full Text] [Related]
13. Performance of the G4 Xpert
Dharan NJ; Blakemore R; Sloutsky A; Kaur D; Alexander RC; Ghajar M; Musser KA; Escuyer VE; Rowlinson MC; Crowe S; Laniado-Laborin R; Valli E; Nabeta P; Johnson P; Alland D
BMC Infect Dis; 2016 Dec; 16(1):764. PubMed ID: 27993132
[TBL] [Abstract][Full Text] [Related]
14. Three year evaluation of Xpert MTB/RIF in a low prevalence tuberculosis setting: A Scottish perspective.
Parcell BJ; Jarchow-MacDonald AA; Seagar AL; Laurenson IF; Prescott GJ; Lockhart M
J Infect; 2017 May; 74(5):466-472. PubMed ID: 28237624
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.
Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y
Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF.
Lombardi G; Di Gregori V; Girometti N; Tadolini M; Bisognin F; Dal Monte P
PLoS One; 2017; 12(4):e0176186. PubMed ID: 28430807
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].
Ciftçi IH; Aslan MH; Aşık G
Mikrobiyol Bul; 2011 Jan; 45(1):43-7. PubMed ID: 21341158
[TBL] [Abstract][Full Text] [Related]
18. Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.
Igarashi Y; Chikamatsu K; Aono A; Yi L; Yamada H; Takaki A; Mitarai S
Diagn Microbiol Infect Dis; 2017 Dec; 89(4):276-281. PubMed ID: 28974394
[TBL] [Abstract][Full Text] [Related]
19. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
Mavenyengwa RT; Shaduka E; Maposa I
Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
